| Financial Year |
March 31 2023 |
| Monetary Funds |
525,974,811.66 |
| Held-for-trading Financial Assets |
80,000,000.00 |
| Notes Receivable |
7,999,648.47 |
| Accounts Receivable |
96,522,610.10 |
| Advances to Suppliers |
44,060,822.84 |
| Other Receivables |
4,503,417.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
499,782,105.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,461,650.98 |
| Total Current Assets |
1,281,989,871.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
59,921,261.60 |
| Investment Properties |
20,553,762.83 |
| Fixed Assetes |
212,645,434.74 |
| Under-construction Projects |
119,848,997.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
130,667,401.91 |
| R&D expenses |
-- |
| Goodwill |
3,723,000.00 |
| Long-Term Deferred and Prepaid Expenses |
3,021,725.18 |
| Deferred Income Tax Assets |
22,680,976.37 |
| Other Non-Current Assets |
137,138.60 |
| Sub-Total of Non-Current Assets |
574,539,673.33 |
| Total Assets |
1,856,529,545.13 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,195,504.14 |
| Accounts Payable |
36,188,403.23 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,744,337.30 |
| Taxes Payable |
7,204,827.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,030,598.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,774,409.04 |
| Other Current Liabilities |
12,918,214.34 |
| Sub-Total of Current Liabilities |
669,874,638.70 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
60,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
991,024.62 |
| Deferred Income Tax Liabilities |
6,514,679.02 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
68,626,991.50 |
| Total Liabilities |
738,501,630.20 |
| Paid-In Capital(Or Share Stock) |
141,609,804.00 |
| Capital Surplus |
403,915,175.83 |
| Surplus Reserve |
37,279,649.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
513,893,008.03 |
| Minority Stockholder's Interest |
17,221,562.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,100,806,352.58 |
| Owner's Equity（Stockholder's Equity） |
1,118,027,914.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,856,529,545.13 |
